• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

英国息肉切除术后监测指南定义的高危人群在首次随访结肠镜检查时出现高级别病变的风险:来自美国单中心的数据。

Risk of advanced lesions at first follow-up colonoscopy in high-risk groups as defined by the United Kingdom post-polypectomy surveillance guideline: data from a single U.S. center.

机构信息

Division of Gastroenterology and Hepatology, Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA.

出版信息

Gastrointest Endosc. 2014 Aug;80(2):299-306. doi: 10.1016/j.gie.2014.02.1029. Epub 2014 May 3.

DOI:10.1016/j.gie.2014.02.1029
PMID:24796960
Abstract

BACKGROUND

The United Kingdom (U.K.) post-adenoma resection guidelines recommend earlier surveillance for patients with 5 or more adenomas or 3 to 4 adenomas of which one is 10 mm or larger compared with U.S. guidelines.

OBJECTIVE

To evaluate the effect of using the U.K. guideline on a U.S. cohort of adenoma patients.

DESIGN

Single-center, retrospective study.

SETTING

Indiana University Hospital and an associated ambulatory surgery center.

PATIENTS

A total of 1414 patients with baseline adenoma findings belonging to one of 5 risk categories and with a follow-up colonoscopy more than 200 days later.

INTERVENTION

Colonoscopy, polypectomy.

MAIN OUTCOME MEASUREMENTS

Incidence of advanced lesions at follow-up colonoscopy.

RESULTS

Advanced neoplasms at follow-up occurred in 16.3% of patients with 5 or more adenomas including 1 that was 10 mm or larger, 8.6% of patients with 3 or 4 adenomas including 1 that was 10 mm or larger, 5% of those with 5 or more adenomas all smaller than 10 mm, 1.8% of those with 3 or 4 adenomas all smaller than 10 mm, and 1.4% of those with 1 to 2 adenomas smaller than 10 mm. Logistic regression analyses showed that the rate of advanced lesions at first follow-up was increased in persons with 3 or more baseline adenomas and at least 1 that is 10 mm or larger compared with those with 1 to 4 small baseline adenomas.

LIMITATIONS

Single-center, retrospective study.

CONCLUSIONS

Our results indicate the U.K. guideline predicts higher risk groups for advanced neoplasia at first follow-up. Our study had inadequate power to show better prediction of incident cancer. Additional study of other databases is warranted.

摘要

背景

与美国指南相比,英国(U.K.)腺瘤切除术后指南建议对有 5 个或更多腺瘤或 3 至 4 个腺瘤且其中 1 个为 10mm 或更大的患者进行更早的监测。

目的

评估在 U.S. 腺瘤患者队列中使用英国指南的效果。

设计

单中心、回顾性研究。

地点

印第安纳大学医院和相关的门诊手术中心。

患者

共有 1414 名基线腺瘤患者,属于 5 个风险类别之一,并且在 200 天以上后进行了随访结肠镜检查。

干预措施

结肠镜检查、息肉切除术。

主要观察指标

随访结肠镜检查中高级别病变的发生率。

结果

在有 5 个或更多包括 1 个 10mm 或更大的腺瘤、3 或 4 个包括 1 个 10mm 或更大的腺瘤的患者中,随访时发生高级别肿瘤的比例分别为 16.3%、8.6%,5 个或更多腺瘤全部小于 10mm 的患者为 5%,3 或 4 个腺瘤全部小于 10mm 的患者为 1.8%,1 至 2 个腺瘤全部小于 10mm 的患者为 1.4%。Logistic 回归分析显示,与 1 至 4 个小基线腺瘤相比,基线有 3 个或更多且至少 1 个为 10mm 或更大的腺瘤的患者首次随访时高级别病变的发生率增加。

局限性

单中心、回顾性研究。

结论

我们的结果表明,英国指南预测首次随访时高级别肿瘤的风险较高。我们的研究没有足够的能力来显示对癌症发病的更好预测。需要对其他数据库进行进一步研究。

相似文献

1
Risk of advanced lesions at first follow-up colonoscopy in high-risk groups as defined by the United Kingdom post-polypectomy surveillance guideline: data from a single U.S. center.英国息肉切除术后监测指南定义的高危人群在首次随访结肠镜检查时出现高级别病变的风险:来自美国单中心的数据。
Gastrointest Endosc. 2014 Aug;80(2):299-306. doi: 10.1016/j.gie.2014.02.1029. Epub 2014 May 3.
2
Five-year risk for advanced colorectal neoplasia after initial colonoscopy according to the baseline risk stratification: a prospective study in 2452 asymptomatic Koreans.根据基线风险分层,首次结肠镜检查后进展性结直肠腺瘤的 5 年风险:2452 例无症状韩国人的前瞻性研究。
Gut. 2011 Nov;60(11):1537-43. doi: 10.1136/gut.2010.232876. Epub 2011 Mar 22.
3
One-year risk for advanced colorectal neoplasia: U.S. versus U.K. risk-stratification guidelines.结肠镜检查后 1 年进展性结直肠腺瘤的风险:美国与英国风险分层指南。
Ann Intern Med. 2012 Dec 18;157(12):856-64. doi: 10.7326/0003-4819-157-12-201212180-00005.
4
Baseline Colonoscopy Findings Associated With 10-Year Outcomes in a Screening Cohort Undergoing Colonoscopy Surveillance.基线结肠镜检查结果与结肠镜筛查监测队列中 10 年结局的相关性。
Gastroenterology. 2020 Mar;158(4):862-874.e8. doi: 10.1053/j.gastro.2019.07.052. Epub 2019 Jul 31.
5
The Risk of Metachronous Advanced Colorectal Neoplasia Rises in Parallel with an Increasing Number of High-Risk Findings at Baseline.异时性晚期结直肠肿瘤的风险与基线时高风险发现数量的增加同步上升。
Gut Liver. 2015 Nov 23;9(6):741-9. doi: 10.5009/gnl14210.
6
Outcomes of EMR of defiant colorectal lesions directed to an endoscopy referral center.内镜转诊中心导向的挑战性结直肠病变内镜黏膜下剥离术的结果。
Gastrointest Endosc. 2012 Aug;76(2):255-63. doi: 10.1016/j.gie.2012.02.060. Epub 2012 May 31.
7
Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society.息肉切除术后结肠镜监测指南:美国结直肠癌多学会特别工作组和美国癌症协会的共识更新
CA Cancer J Clin. 2006 May-Jun;56(3):143-59; quiz 184-5. doi: 10.3322/canjclin.56.3.143.
8
Risk of advanced colorectal neoplasm by the proposed combined United States and United Kingdom risk stratification guidelines.按美国和英国联合提出的风险分层指南评估结直肠进展性腺瘤的风险。
Gastrointest Endosc. 2018 Mar;87(3):800-808. doi: 10.1016/j.gie.2017.09.023. Epub 2017 Oct 3.
9
Adenoma surveillance and colorectal cancer incidence: a retrospective, multicentre, cohort study.腺瘤监测与结直肠癌发病率:一项回顾性、多中心、队列研究。
Lancet Oncol. 2017 Jun;18(6):823-834. doi: 10.1016/S1470-2045(17)30187-0. Epub 2017 Apr 28.
10
Risk of Metachronous Advanced Neoplasia in Patients With Multiple Diminutive Adenomas.多发性微小腺瘤患者的异时性高级别肿瘤风险。
Am J Gastroenterol. 2018 Dec;113(12):1855-1861. doi: 10.1038/s41395-018-0210-9. Epub 2018 Aug 3.

引用本文的文献

1
Provider Adherence to the 2020 US Multi-Society Task Force Guidelines for Surveillance After Colonoscopy With Polypectomy.医疗服务提供者对2020年美国多学会工作组关于息肉切除术后结肠镜检查监测指南的遵循情况。
Gastro Hep Adv. 2024 Aug 23;4(1):100532. doi: 10.1016/j.gastha.2024.08.011. eCollection 2025.
2
Post-polypectomy surveillance: follow-up recommendations from the Alberta Colorectal Cancer Screening Program.息肉切除术后监测:艾伯塔省结直肠癌筛查项目的随访建议
J Can Assoc Gastroenterol. 2024 Mar 19;7(4):319-328. doi: 10.1093/jcag/gwae007. eCollection 2024 Aug.
3
Risk of advanced neoplasia after removal of colorectal adenomas with high-grade dysplasia.
高级别异型增生的结直肠腺瘤切除后发生进展性肿瘤的风险。
Surg Endosc. 2024 Jul;38(7):3783-3798. doi: 10.1007/s00464-024-10898-5. Epub 2024 May 28.
4
Risk Prediction of Metachronous Colorectal Cancer from Molecular Features of Adenomas: A Nested Case-Control Study.腺瘤分子特征预测结直肠腺瘤患者的异时性结直肠癌风险:巢式病例对照研究。
Cancer Res Commun. 2023 Nov 13;3(11):2292-2301. doi: 10.1158/2767-9764.CRC-23-0186.
5
Low Incidence of Colorectal Advanced Neoplasia During Surveillance in Individuals with a Family History of Colorectal Cancer.有结直肠癌家族史个体在监测期间结直肠高级别瘤变的低发病率
Dig Dis Sci. 2023 Nov;68(11):4243-4251. doi: 10.1007/s10620-023-08053-6. Epub 2023 Sep 8.
6
Risk stratification for the detection of metachronous polyps after bowel screening polypectomy: clinical outcomes from the Integrated Technologies for Improved Polyp Surveillance (INCISE) study cohort.肠筛查息肉切除术后检测同时性息肉的风险分层:来自集成技术改善息肉监测(INCISE)研究队列的临床结果。
BJS Open. 2023 May 5;7(3). doi: 10.1093/bjsopen/zrad034.
7
Korean Guidelines for Postpolypectomy Colonoscopic Surveillance: 2022 revised edition.韩国息肉切除术后结肠镜监测指南:2022年修订版
Intest Res. 2023 Jan;21(1):20-42. doi: 10.5217/ir.2022.00096. Epub 2023 Jan 31.
8
Korean guidelines for postpolypectomy colonoscopic surveillance: 2022 revised edition.韩国息肉切除术后结肠镜监测指南:2022年修订版
Clin Endosc. 2022 Nov;55(6):703-725. doi: 10.5946/ce.2022.136. Epub 2022 Oct 13.
9
Total polyp number may be more important than size and histology of polyps for prediction of metachronous high-risk colorectal neoplasms.总的息肉数量可能比息肉的大小和组织学更重要,可用于预测同时发生的高风险结直肠肿瘤。
BMC Gastroenterol. 2022 Mar 2;22(1):91. doi: 10.1186/s12876-022-02177-1.
10
New risk stratification after colorectal polypectomy reduces burden of surveillance without increasing mortality.结直肠息肉切除术后的新风险分层可降低监测负担而不增加死亡率。
United European Gastroenterol J. 2021 Oct;9(8):947-954. doi: 10.1002/ueg2.12119. Epub 2021 Aug 3.